|Concluded, no further activity expected
|Study Start Date:
|Study Made Public:
Open-label, multi-site study for the administration of vaccinia immune globulin (human) to subjects who experience complications from vaccinia virus vaccinations or to unprotected individuals accidentally exposed to vaccinia virus or related orthopox viruses
HVTN 801 (AVEG 801) is a non-HIV emergency treatment study for administration of human vaccinia immune globulin (VIG) to individuals who experience complications after receiving or being exposed to vaccinia-based vaccinations.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.